X 
Board Meetings
Home | Market Info | Company Profile | Board Meetings
Solara Active Pharma Sciences Ltd.
BSE CODE: 541540   |   NSE CODE: SOLARA   |   ISIN CODE : INE624Z01016   |   15-May-2026 Hrs IST
BSE NSE
Rs. 579.45
72.6 ( 14.32% )
 
Prev Close ( Rs.)
506.85
Open ( Rs.)
544.85
 
High ( Rs.)
599.75
Low ( Rs.)
501.95
 
Volume
185126
Week Avg.Volume
37656
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 579.90
72.2 ( 14.22% )
 
Prev Close ( Rs.)
507.70
Open ( Rs.)
514.10
 
High ( Rs.)
598.50
Low ( Rs.)
502.00
 
Volume
4013707
Week Avg.Volume
773526
 
52 WK High-Low Range(Rs.)
422
734.4
Source DateBoard Meeting DateDetails
08-May-2026 15-May-2026 Audited Results
19-Mar-2026 24-Mar-2026 Inter alia, to consider and approve :- a) To consider making Second and Final Call on partly paid-up Equity Shares issued by the Company on rights basis in accordance with the Letter of Offer dated May 09, 2024. b) To fix the Record Date for the purpose of determining the eligible shareholders for payment of the said call money. c) Any other matters, which may be incidental and ancillary to making aforesaid Second and Final call.
30-Jan-2026 06-Feb-2026 Quarterly Results
29-Oct-2025 05-Nov-2025 Quarterly Results
18-Jul-2025 25-Jul-2025 Quarterly Results
07-May-2025 15-May-2025 Audited Results
26-Mar-2025 02-Apr-2025 Inter-alia, to consider and approve:- (1) the First Call money Notice, on the partly paid Equity Shares issued on Rights basis which is to be sent to the eligible Shareholders
20-Mar-2025 26-Mar-2025 Inter alia, to consider and approve :- a) To consider and approve, a proposal of making First Call on 1,19,98,755 partly paid-up Equity Shares, having a face value of Rs.10/- each (Rs.3.50/- paid-up) issued by the Company on rights basis in accordance with the Letter of Offer dated May 09, 2024. b) Any other matters, which may be incidental and ancillary to making aforesaid first call.
16-Jan-2025 24-Jan-2025 Quarterly Results
14-Oct-2024 21-Oct-2024 Quarterly Results
Page 1 of 4
PREV || NEXT